News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
FDA Says MedImmune, Inc. Flu Vaccine Works in Children Under Age 5, but Raises Some Safety Concerns
May 14, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, May 14 (Reuters) - Data for MedImmune Inc.'s (MEDI.O: Quote, Profile , Research) Flumist show the influenza vaccine is effective for children younger than 5 years old, U.S. regulatory staff said in a review released on Monday.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
Shutdown Pauses New Drug Reviews, CDC Issues New COVID Guidance, CGT Meets on Mesa
October 8, 2025
·
1 min read
·
Heather McKenzie
Obesity
Skye’s CB1 Inhibitor Shows ‘Intriguing Synergy’ With Wegovy, Despite Mid-Stage Obesity Fail
October 7, 2025
·
2 min read
·
Tristan Manalac
Opinion
Gene Therapy’s Future Hinges on the Economics of Safety
October 6, 2025
·
7 min read
·
Ronald A. Li
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
October 6, 2025
·
5 min read
·
Ben Hargreaves